Together Pharma Ltd (TLV:TGTR)
Israel · Delayed Price · Currency is ILS · Price in ILA 204.00
-2.70 (-1.31%)
Sep 3, 2026, 11:08 AM IDT
Together Pharma Ratios and Metrics
Market cap in millions ILS. Fiscal year is January - December.
Millions ILS. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 36 | 58 | 54 | 34 | 19 | 68 | |
Market Cap Growth | -42.82% | 7.36% | 58.74% | 82.58% | -72.51% | -50.07% |
Enterprise Value | 96 | 101 | 112 | 92 | 61 | 138 |
Last Close Price | 2.07 | 3.35 | 3.92 | 3.88 | 2.48 | 10.62 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | 30.38 | - | - | - | - |
PS Ratio | 0.36 | 0.53 | 0.56 | 0.38 | 0.60 | 5.65 |
PB Ratio | 0.74 | 1.16 | 1.42 | -13.36 | 6.18 | 2.64 |
P/TBV Ratio | 1.50 | 2.46 | 6.29 | - | - | - |
P/FCF Ratio | - | 11.25 | 39.38 | 2.44 | - | - |
P/OCF Ratio | - | 8.83 | 18.99 | 2.30 | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.96 | 0.92 | 1.16 | 1.01 | 1.97 | 11.50 |
EV/EBITDA Ratio | 5.29 | 4.76 | 12.52 | 3.33 | - | - |
EV/EBIT Ratio | 9.26 | 6.65 | 34.17 | 4.16 | - | - |
EV/FCF Ratio | - | 19.59 | 81.38 | 6.58 | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 1.30 | 1.19 | 1.66 | -21.48 | 19.88 | 3.32 |
Debt / EBITDA Ratio | 3.49 | 2.62 | 6.29 | 1.92 | - | - |
Debt / FCF Ratio | - | 11.57 | 46.26 | 3.92 | - | - |
Net Debt / Equity Ratio | 1.19 | 0.95 | 1.44 | -20.07 | 18.13 | 3.12 |
Net Debt / EBITDA Ratio | 3.48 | 2.23 | 6.17 | 1.85 | -3.81 | -13.08 |
Net Debt / FCF Ratio | -6.22 | 9.20 | 40.12 | 3.67 | -3.89 | -3.98 |
Asset Turnover | 0.65 | 0.73 | 0.67 | 0.68 | 0.22 | 0.09 |
Inventory Turnover | 1.21 | 1.31 | 1.41 | 1.13 | 0.82 | 0.34 |
Quick Ratio | 0.43 | 0.41 | 0.36 | 0.27 | 0.29 | 0.09 |
Current Ratio | 1.26 | 1.32 | 1.07 | 1.17 | 1.25 | 1.32 |
Return on Equity (ROE) | -2.08% | 4.34% | -9.09% | -1076.01% | -246.99% | -74.80% |
Return on Assets (ROA) | 4.22% | 6.32% | 1.43% | 10.29% | -8.57% | -5.04% |
Return on Invested Capital (ROIC) | 9.74% | 6.28% | 3.86% | -54.24% | -24.14% | -13.31% |
Return on Capital Employed (ROCE) | 13.60% | 18.40% | 4.80% | 28.90% | -24.00% | -12.40% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -1.42% | 3.29% | -2.17% | -12.66% | -179.57% | -20.28% |
FCF Yield | -25.98% | 8.89% | 2.54% | 40.97% | -75.34% | -29.70% |
Buyback Yield / Dilution | -23.93% | -27.26% | -41.39% | -7.81% | -18.96% | -18.76% |